The association of breast cancer patients survival and prior menopausal hormone therapy in women with type 2 diabetes – Nature.com

Shao, S. et al. Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiol. Biomarkers Prev. 27, 5057 (2018).

Article PubMed Google Scholar

Lee, K. N. et al. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status. PLoS ONE 15, e0232581 (2020).

Article CAS PubMed PubMed Central Google Scholar

Luo, J. et al. Pre-existing diabetes and breast cancer prognosis among elderly women. Br. J. Cancer 113, 827832 (2015).

Article CAS PubMed PubMed Central Google Scholar

Nelson, H. D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291, 16101620 (2004).

Article CAS PubMed Google Scholar

Maclennan, A. H., Broadbent, J. L., Lester, S. & Moore, V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst. Rev. 2004, CD002978 (2004).

PubMed PubMed Central Google Scholar

The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29, 767794 (2022).

Stuenkel, C. A. et al. Treatment of symptoms of the menopause: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 39754011 (2015).

Article CAS PubMed Google Scholar

McVicker, L. et al. Vaginal estrogen therapy use and survival in females with breast cancer. JAMA Oncol. 10, 103108 (2024).

Article PubMed Google Scholar

Beral, V. & Million,. Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet 362, 419427 (2003).

Article CAS Google Scholar

Henderson, B. E., Paganini-Hill, A. & Ross, R. K. Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med. 151, 7578 (1991).

Article CAS PubMed Google Scholar

Fletcher, A. S. et al. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis. Breast 14, 192200 (2005).

Article CAS PubMed Google Scholar

Newcomb, P. A. et al. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol. Biomarkers Prev. 17, 864871 (2008).

Article CAS PubMed PubMed Central Google Scholar

Rosenberg, L. U. et al. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: A cohort study. Breast Cancer Res. 10, R78 (2008).

Article PubMed PubMed Central Google Scholar

Rauh, C. et al. Hormone therapy and its effect on the prognosis in breast cancer patients. Geburtshilfe Frauenheilkd 75, 588596 (2015).

Article CAS PubMed PubMed Central Google Scholar

Schuetz, F. et al. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Am. J. Obstet. Gynecol. 196(342), e1-9 (2007).

Google Scholar

Sener, S. F. et al. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. Am. J. Surg. 197, 403407 (2009).

Article CAS PubMed Google Scholar

Obi, N. et al. Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort. Int. J. Cancer 138, 20982108 (2016).

Article CAS PubMed Google Scholar

Strickland, D. M., Gambrell, R. D., Butzin, C. A. & Strickland, K. The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet. Gynecol. 80, 400404 (1992).

CAS PubMed Google Scholar

Manson, J. E. et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Womens Health Initiative randomized trials. JAMA 310, 13531368 (2013).

Article CAS PubMed Google Scholar

Anagnostis, P. et al. Menopausal hormone therapy and cardiovascular risk: Where are we now?. Curr. Vasc. Pharmacol. 17, 564572 (2019).

Article CAS PubMed Google Scholar

Wolf, P. H., Madans, J. H., Finucane, F. F., Higgins, M. & Kleinman, J. C. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort. Am. J. Obstet. Gynecol. 164, 489494 (1991).

Article CAS PubMed Google Scholar

Grodstein, F. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133, 933 (2000).

Article CAS PubMed Google Scholar

Petitti, D. B., Sidney, S. & Quesenberry, C. P. Hormone replacement therapy and the risk of myocardial infarction in women with coronary risk factors. Epidemiology 11, 603606 (2000).

Article CAS PubMed Google Scholar

Rossouw, J. E. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the womens health initiative randomized controlled trial. JAMA 288, 321333 (2002).

Article CAS PubMed Google Scholar

Nie, G. et al. The effects of menopause hormone therapy on lipid profile in postmenopausal women: A systematic review and meta-analysis. Front. Pharmacol. 12, 850815 (2022).

Article Google Scholar

Sund, R. Quality of the finnish hospital discharge register: A systematic review. Scand. J. Public Health 40, 505515 (2012).

Article PubMed Google Scholar

Pukkala, E. et al. Nordic cancer registriesAn overview of their procedures and data comparability. Acta Oncol. 57, 440455 (2018).

Article PubMed Google Scholar

Lahti, R. A. & Penttil, A. The validity of death certificates: Routine validation of death certification and its effects on mortality statistics. Forensic Sci. Int. 115, 1532 (2001).

Article CAS PubMed Google Scholar

Stahlberg, C. et al. Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapya prospective observational study. Int. J. Epidemiol. 34, 931935 (2005).

Article PubMed Google Scholar

Ewertz, M., Gillanders, S., Meyer, L. & Zedeler, K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int. J. Cancer 49, 526530 (1991).

Article CAS PubMed Google Scholar

Yu, X. et al. Hormone replacement therapy and breast cancer survival: A systematic review and meta-analysis of observational studies. Breast Cancer 24, 643657 (2017).

Article PubMed Google Scholar

Britt, K. L., Cuzick, J. & Phillips, K. A. Key steps for effective breast cancer prevention. Nat. Rev. Cancer 20, 417436 (2020).

Article CAS PubMed Google Scholar

Zaluzec, E. K. & Sempere, L. F. Systemic and local strategies for primary prevention of breast cancer. Cancers 16, 248 (2024).

Article CAS PubMed PubMed Central Google Scholar

Kotsopoulos, J. et al. Bilateral oophorectomy and all-cause mortality in women with BRCA1 and BRCA2 sequence variations. JAMA Oncol. 10, 484492 (2024).

Article PubMed Google Scholar

Palme, M. & Simeonova, E. Does womens education affect breast cancer risk and survival? Evidence from a population based social experiment in education. J. Health Econ. 42, 115124 (2015).

Article PubMed Google Scholar

Magnusson, C., Holmberg, L., Nordn, T., Lindgren, A. & Persson, I. Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res. Treat 38, 325334 (1996).

Article CAS PubMed Google Scholar

Godina, C. et al. Prognostic impact of menopausal hormone therapy in breast cancer differs according to tumor characteristics and treatment. Front. Oncol. 10, 80 (2020).

Article PubMed PubMed Central Google Scholar

Green, J. et al. Cohort profile: The million women study. Int. J. Epidemiol. 48, 2829e (2019).

Article PubMed Google Scholar

Harman, S. M. et al. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am. J. Med. 124, 199205 (2011).

Article ADS CAS PubMed PubMed Central Google Scholar

Nudy, M., Chinchilli, V. M. & Foy, A. J. A systematic review and meta-regression analysis to examine the timing hypothesis of hormone replacement therapy on mortality, coronary heart disease, and stroke. Int. J. Cardiol. Heart Vasc. 22, 123131 (2019).

PubMed PubMed Central Google Scholar

von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344349 (2008).

Article Google Scholar

Arffman, M. et al. FinDM database on diabetes in Finland. (2020).

Sund, R., Harno, K., Ranta, S. & Tolppanen, E. Evaluation of case inclusion in two population-based diabetes registers. Finn. J. eHealth eWelfare 2, 136146 (2010).

Google Scholar

Putter, H., Fiocco, M. & Geskus, R. B. Tutorial in biostatistics: Competing risks and multi-state models. Stat. Med. 26, 23892430 (2007).

Article MathSciNet CAS PubMed Google Scholar

deGlas, N. A. et al. Performing survival analyses in the presence of competing risks: A clinical example in older breast cancer patients. J. Nat. Cancer Inst. 108, 1 (2016).

Google Scholar

Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515526 (1994).

Article MathSciNet Google Scholar

Therneau, T. _A Package for Survival Analysis in S_version 2.38. (2015).

Team, R. C. R: A language and environment for statistical computing. (R Foundation for Statistical Computing, 2017).

Continued here:
The association of breast cancer patients survival and prior menopausal hormone therapy in women with type 2 diabetes - Nature.com